Walmart, Inc. engages in retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a merchandiser of consumer products, operating under the Walmart, Wal-Mart, and Walmart Neighborhood Market brands, as well as walmart.com and other eCommerce brands. The Walmart International segment manages supercenters, supermarkets, hypermarkets, warehouse clubs, and cash and carry outside of the United States. The Sam's Club segment consists of membership-only warehouse clubs and samsclubs.com. The company was founded by Samuel Moore Walton and James Lawrence Walton in 1945 and is headquartered in Bentonville, AR.
Clinical Trials
0
0 active
Approvals
90
Total approvals
Agencies
1
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No trial data available
- A multistate Salmonella Javiana outbreak has sickened 345 people across 27 states, with 36 hospitalizations and zero deaths reported as of August 2026. - Epidemiological investigation traced the source to jalapeño peppers imported from Sinaloa, Mexico, and distributed by Coast Citrus Distributors to restaurants including Chipotle and QDOBA. - The USDA FSIS issued a public health alert for 18 meat and poultry products containing the recalled jalapeños, sold under brands including Taylor Farms, Marketside, and H-E-B. - Both Chipotle and QDOBA have ceased using the implicated jalapeños, and the FDA does not consider there to be an ongoing risk from these establishments.
- Magic Molecule's FDA-cleared Daily Skin Spray will launch in more than 4,500 Walmart stores nationwide and on Walmart.com, expanding its retail footprint to over 16,500 locations. - The hypochlorous acid (HOCl) skincare brand reports 500% year-over-year retail revenue growth, driven by partnerships with Target, Ulta Beauty, and CVS. - The product supports the skin's natural recovery process for over 50 common skin concerns and is safe for all ages one month and up. - The launch positions Magic Molecule as the first hypochlorous acid skincare brand to stock Walmart's shelves, advancing accessibility of the fast-growing category.
- Consumer Reports tested 52 rice products and detected measurable inorganic arsenic, a known carcinogen, in every single sample. - More than 40% of tested products contained arsenic levels high enough that one serving per day could raise the risk of cancer and type 2 diabetes over time. - Brown rice generally contained more inorganic arsenic than white rice, while basmati and sushi rice tended to have lower levels. - Consumer Reports is urging the FDA to set arsenic limits on all rice products, noting that no level of arsenic is considered safe.
- Walmart and Sam's Club announced a nationwide effort to help Medicare beneficiaries understand new prescription drug coverage options for weight management and chronic conditions. - The initiative provides pharmacist consultations, educational materials, and digital health navigation tools across nearly 5,000 locations, including rural and underserved communities. - Approximately 90% of the U.S. population lives within 10 miles of a Walmart, positioning its pharmacy network as a critical access point for healthcare information. - The program focuses on education and navigation support, while eligibility determinations and treatment decisions remain with government programs, health plans, and providers.
- UVA researchers analyzed 352 over-the-counter probiotic products from major U.S. pharmacy chains and found only 36 unique bacterial species, with no consistency in formulations linked to health claims. - The team developed HaPaPro, a collection of over 1,000 computer models of bacterial metabolism, to rationally design microbiome-targeted therapies. - Using HaPaPro, researchers successfully identified microbes with potential to prevent bacterial vaginosis, demonstrating the platform's therapeutic promise. - Findings published in Nature Microbiology highlight how computational modeling could lead to evidence-based probiotic products that deliver on their marketed health promises.
- Walmart, Costco, Amazon, and CVS are leveraging direct-to-consumer GLP-1 programs to capture patients losing employer-sponsored coverage for weight-loss drugs like Wegovy and Zepbound. - A Mercer survey shows 6% of large employers dropped GLP-1 coverage this year, with the drugs' share of claims swelling to 11.4% from 6.9% in 2023. - Retailers view GLP-1 prescriptions as a gateway to recurring customer relationships, with pharmacy visits driving grocery and merchandise sales across their networks. - Independent pharmacies face significant disadvantages, raising safety concerns about drug interaction monitoring when patients fill GLP-1 prescriptions at multiple locations.
- SKYX Platforms Corp. closed a $25 million funding round from a fundamental institutional investor at $2.50 per share to support working capital and general corporate purposes. - The company announced a collaboration with NVIDIA's AI Ecosystem Connect Program to integrate AI capabilities into existing and future smart home projects. - SKYX launched its patented SKYFAN and Turbo Heater products at major U.S. retailers including Home Depot, Target, Walmart, and Lowe's, with revenues increasing for seven consecutive quarters. - The company expects to deploy over 1 million units of its plug-and-play technologies across upcoming smart home and smart city projects in North Carolina, Texas, Florida, Saudi Arabia, and Egypt.
- Walmart will open clinical research sites this spring in three former Walmart Health locations and one rural store through partnership with Care Access research organization. - The initiative aims to address barriers to clinical trial participation by bringing research opportunities closer to underrepresented communities including rural residents and minorities. - Sites will offer health screenings and information about research studies, potentially providing participants early access to innovative treatments and therapies. - The expansion comes amid FDA efforts to improve diversity in clinical trials, as racial and ethnic minorities remain frequently underrepresented in biomedical research.
- TempraMed Technologies has launched VIVI Cap Smart, the world's first platform that combines temperature protection with digital tracking for insulin and GLP-1 pens. - The device integrates proprietary space-grade thermal insulation technology with digital health functionality, enabling automatic injection timing tracking and medication logging through a connected mobile application. - This launch represents TempraMed's strategic transition toward a comprehensive patient platform that combines physical device innovation with digital tools for chronic disease management. - The company has already achieved significant commercial traction with over 120,000 devices sold globally and distribution through major retailers and healthcare organizations including Maccabi Healthcare Services.
- Arena BioWorks, a biomedical research institute backed by $500 million from billionaire investors including Michael Dell, is abruptly shutting down less than two years after its January 2024 launch. - The closure will result in approximately 50 layoffs, including co-founder Stuart Schreiber and CEO Harvey Berger, as the company cites "policy uncertainty and weak funding" in the current biotech environment. - Despite claims of "major advances" in oncology, immune disorders, and brain health, Arena's scientific discoveries will be transferred to its scientists for potential future development outside the company. - The shutdown follows Arena's August 2024 downsizing that eliminated 30% of its workforce as the company pivoted away from cell and gene therapies to focus on small-molecule and biologic treatments.
